Dr. Reddy's Laboratories enters into a licensing agreement with Slayback Pharma

Dr. Reddy's Laboratories updates on PAI of formulations facility

The company has been issued a Form 483 with two observations which the company will address within the stipulated timeline.

JB Pharma acquires 4 paediatric brands from Dr Reddy’s Laboratories

The total covered market size of four brands – Z&D, Pediclory, Pecef & Ezinapi combined is Rs 1800 crores

Dr. Reddy's Laboratories announces conclusion of patent litigation with Indivior

The settlement and dismissal resolves all claims between the parties

Dr. Reddy's Laboratories acquires injectable product portfolio from Eton Pharma

Dr. Reddy's acquired the Eton portfolio for an upfront payment of approximately $5 million in cash, plus contingent payments of up to $45 million.

IPCA Laboratories posts Rs. 130.23 crores consolidated profit in Q4FY22

The company has posted net profit of Rs.884.08 crores for the Financial Year ended March 31, 2022.

HCmed, Formosa Laboratories, and Formosa Pharmaceuticals form CDMO

According to statistics, the global inhalation drug market reached US $ 25 billion in 2020

Hilleman Laboratories invests US $ 58 mn to establish vaccine hub in Singapore

The facility will supply clinical trial materials for the development of vaccines and biologics up to Phase II stage and is expected to be fully operational by early 2023.

Ipca Laboratories acquires 26 % stake in Lyka Labs, makes open offer

For the six months ended September 30, 2021, Lyka had reported revenues of Rs 109.87 crore

Dr Reddys Laboratories posts Q2FY22 PAT at Rs 992 Cr

Dr. Reddy's Laboratories has reported consolidated financial results for the period ended September 30, 2021